Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
AKTS
#7638
Aktis Oncology, Inc. Common stock
20.1
3
+4.95%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+4.95%
Monthly Change
-2.66%
6 month change
-25.44%
Year Change
-25.44%
Previous Close
19.1
8
Open
20.1
3
Bid
Ask
Low
20.1
3
High
20.1
3
Volume
12
Markets
US Stock Market
Technology
AKTS
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
No data
News
BofA Securities initiates coverage on Akoustis Technologies stock with Buy rating
Cowen initiates Akoustis Technologies stock with Buy rating
Akoustis Technologies stock initiated with Overweight rating by JPMorgan
Wednesday Insider Activity: Mitsui’s $55.6M Berkley Buy Leads the Pack
Aktis Oncology director Foley buys $4.19 million in shares
Aktis Oncology: Mpm funds buy shares worth $20m
Aktis Oncology (AKTS) sees $20 million purchase by 10% owner
BMO Capital reiterates Outperform rating on Eli Lilly stock at $1,200
Aktis Oncology director Nodelman buys $40 million in shares
U.S. IPO Weekly Recap: Aktis Oncology Leads As First Sizable 2026 IPO
Aktis Oncology shares surge 50% in Nasdaq debut
Aktis Oncology Jumps 27% After $318 Million Upsized IPO